IGF2BP1 and cervical squamous cell carcinoma: Low methylation levels of IGF2BP1/2/3 have been associated with poor prognosis in some tumors (KIRC, CESC, LUAD, SKCM, KIRP and HNSC), potentially due to the activation and expression of IGF2BPs.